FINNENCE ▪ THE WIRE FILE
THE WIRE · № 84576
News▲ Bullish
Updated: City Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi field
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A $200M biotech IPO signals reopening risk appetite for early-stage RNAi drug developers.
Biotech IPO signals selective funding window reopening
CATALYST TO WATCH
Aftermarket trading and follow-on deals
MAIN RISK
Early-stage biotech carries high clinical risk
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
AFFECTEDSPDR Biotech ETF · XBI
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Brayton Purcell LLP Welcomes Federal Bill Addressing Artificial Stone Silicosis Epidemic2026-10-16 17:44 UTC
Brayton Purcell LLP Welcomes Federal Bill Addressing Artificial Stone Silicosis Epidemic2026-10-16 17:44 UTC
→CORRELATIONshares Healthcare
Youngstown Orthopaedic Associates Joins Cleveland Clinic and Dr. James D. Solmen Retires2026-10-16 17:54 UTC
Youngstown Orthopaedic Associates Joins Cleveland Clinic and Dr. James D. Solmen Retires2026-10-16 17:54 UTC
→CORRELATIONshares XBI, Healthcare
City Therapeutics surges in market debut after upsizing $200M IPO2026-10-16 17:13 UTC
City Therapeutics surges in market debut after upsizing $200M IPO2026-10-16 17:13 UTC
→CORRELATIONshares XBI, Healthcare
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver2026-10-16 17:48 UTC
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver2026-10-16 17:48 UTC
→CORRELATIONshares Healthcare
IPO market review: biotech leads a quiet week as Anthropic waits in the queue2026-10-16 17:38 UTC
IPO market review: biotech leads a quiet week as Anthropic waits in the queue2026-10-16 17:38 UTC
←CORRELATIONshares Healthcare
A stock sale is expected to bring City Therapeutics about $200 million.2026-10-16 02:37 UTC
A stock sale is expected to bring City Therapeutics about $200 million.2026-10-16 02:37 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.